Vascular Effects of Estrogen and Cholesterol-Lowering Therapies in Hypercholesterolemic Postmenopausal Women (original) (raw)
Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women
M. Erenus
European Heart Journal, 2000
View PDFchevron_right
Lipid profiles and endothelial function with low-dose hormone replacement therapy in postmenopausal women at risk for coronary artery disease: a randomized trial
massimo fini
International Journal of Cardiology, 2003
View PDFchevron_right
Transdermal estrogen reduces vascular resistance and serum cholesterol in postmenopausal women
Susan Girdler
American Journal of Obstetrics and Gynecology, 2001
View PDFchevron_right
Oral low-dose estradiol plus norethisterone acetate with or without simvastatin in dyslipidemic and symptomatic menopausal women: A randomized clinical trial
Cesar Fernandes
Health, 2013
View PDFchevron_right
The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
Anne Jacobsen
Journal of Internal Medicine, 2000
View PDFchevron_right
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the women’s ischemia syndrome evaluation (WISE)
Sarah Berga
The American Journal of Medicine, 2002
View PDFchevron_right
Vascular Effects of Estrogen and Vitamin E Therapies in Postmenopausal Women
Neta Blum
Circulation, 1999
View PDFchevron_right
Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents
J. Scali
Climacteric, 2008
View PDFchevron_right
Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial
Dhananjay Vaidya
Atherosclerosis, 2005
View PDFchevron_right
Aggressive Versus Moderate Lipid-Lowering Therapy in Hypercholesterolemic Postmenopausal Women: Beyond Endorsed Lipid Lowering With EBT Scanning (BELLES)
Francine Welty
Circulation, 2005
View PDFchevron_right
Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial
Rachel Laskey
American Heart Journal, 2001
View PDFchevron_right
Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause
Intira Sriprasert
The Journal of Clinical Endocrinology & Metabolism
View PDFchevron_right
Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial
Frank Stanczyk
Atherosclerosis, 2003
View PDFchevron_right
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal women
Jean-marie Bard
Journal of Internal Medicine, 1995
View PDFchevron_right
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women
Jean-marie Bard
Journal of Internal Medicine
View PDFchevron_right
Lipid-altering efficacy and safety of simvastatin in women and elderly patients with hypercholesterolemia
Evan Stein
Atherosclerosis, 2000
View PDFchevron_right
Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor …
Nasrin Nahar
Journal of Clinical …, 2005
View PDFchevron_right
Hormone replacement therapy and endothelial function:: Results of a randomized controlled trial in healthy postmenopausal women
Miriam de Kleijn
Atherosclerosis, 2001
View PDFchevron_right
Raloxifene and estrogen reduces progression of advanced atherosclerosis — a study in ovariectomized, cholesterol-fed rabbits
Raymond Kauffman
2001
View PDFchevron_right
Effect of statins on estrogen and androgen levels in postmenopausal women treated with estradiol
Barbara Stanczyk
Climacteric, 2010
View PDFchevron_right
Significant Differential Effects of Hormone Therapy or Tibolone on Markers of Cardiovascular Disease in Postmenopausal Women
Hyun Kim
Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
View PDFchevron_right
Hormone replacement therapy reduces lipid oxidation directly at the arterial wall: A possible link to estrogens' cardioprotective effect through atherosclerosis prevention
Silvia Quesada Mora
Journal of mid-life health
View PDFchevron_right
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow
Cesar Eduardo
Maturitas, 2008
View PDFchevron_right
Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women
Bela Asztalos
Atherosclerosis, 2009
View PDFchevron_right
The Direct Antiatherogenic Effect of Estrogen Is Present, Absent, or Reversed, Depending on the State of the Arterial Endothelium A Time Course Study in Cholesterol-Clamped Rabbits
Malene Andersen
View PDFchevron_right
Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial
Clemens von Schacky
Journal of the American College of Cardiology, 2000
View PDFchevron_right
Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia
Michiya Igase
Menopause: The Journal of The North American Menopause Society, 2012
View PDFchevron_right
Vascular effects of estrogen in type II diabetic postmenopausal women
tae yong ahn
Journal of the American College of Cardiology, 2001
View PDFchevron_right
Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women
Wayne H.-h. Sheu
Human Reproduction, 2006
View PDFchevron_right
HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal women
Peter Kenemans
Fertility and Sterility, 2004
View PDFchevron_right
Antiatherogenic effect of simvastatin is not due to decrease of LDL cholesterol in ovariectomized golden Syrian hamster
Jan Kovar
Physiological research / Academia Scientiarum Bohemoslovaca, 2010
View PDFchevron_right